Works matching IS 13479032 AND DT 2022 AND VI 113 AND IP 12
Results: 35
Reviewers.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4401, doi. 10.1111/cas.15670
- Publication type:
- Article
Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4151, doi. 10.1111/cas.15593
- By:
- Publication type:
- Article
Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4300, doi. 10.1111/cas.15586
- By:
- Publication type:
- Article
NUSAP1, a novel stemness‐related protein, promotes early recurrence of hepatocellular carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4165, doi. 10.1111/cas.15585
- By:
- Publication type:
- Article
m6A modification–mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4135, doi. 10.1111/cas.15581
- By:
- Publication type:
- Article
Resveratrol inhibits development of colorectal adenoma via suppression of LEF1; comprehensive analysis with connectivity map.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4374, doi. 10.1111/cas.15576
- By:
- Publication type:
- Article
BRCA1 transports the DNA damage signal for CDDP‐induced centrosome amplification through the centrosomal Aurora A.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4230, doi. 10.1111/cas.15573
- By:
- Publication type:
- Article
p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case‐cohorts within a Japanese prospective study.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4385, doi. 10.1111/cas.15572
- By:
- Publication type:
- Article
Hsa‐microRNA‐370‐3p targeting Snail and Twist1 suppresses IL‐8/STAT3‐driven hepatocellular carcinoma metastasis.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4120, doi. 10.1111/cas.15571
- By:
- Publication type:
- Article
Carcinogenesis resistance in the longest‐lived rodent, the naked mole‐rat.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4030, doi. 10.1111/cas.15570
- By:
- Publication type:
- Article
Pentraxin 3 is an adipose tissue‐related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4311, doi. 10.1111/cas.15569
- By:
- Publication type:
- Article
The emerging multifaceted role of PINK1 in cancer biology.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4037, doi. 10.1111/cas.15568
- By:
- Publication type:
- Article
TIMP1 promotes cell proliferation and invasion capability of right‐sided colon cancers via the FAK/Akt signaling pathway.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4244, doi. 10.1111/cas.15567
- By:
- Publication type:
- Article
Combined chemoradiotherapy and programmed cell death‐ligand 1 blockade leads to changes in the circulating T‐cell receptor repertoire of patients with non‐small‐cell lung cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4394, doi. 10.1111/cas.15566
- By:
- Publication type:
- Article
Pathological complete remission of relapsed tumor by photo‐activating antibody–mimetic drug conjugate treatment.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4350, doi. 10.1111/cas.15565
- By:
- Publication type:
- Article
Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010).
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4327, doi. 10.1111/cas.15564
- By:
- Publication type:
- Article
Suppression of high mobility group box 1 in B16F10 tumor does not inhibit the induction of neoantigen‐specific T cells.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4082, doi. 10.1111/cas.15563
- By:
- Publication type:
- Article
CT and CEA‐based machine learning model for predicting malignant pulmonary nodules.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4363, doi. 10.1111/cas.15561
- By:
- Publication type:
- Article
Risk‐adapted stereotactic body radiotherapy for patients with cervical spinal metastases.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4277, doi. 10.1111/cas.15559
- By:
- Publication type:
- Article
Inhibition of insulin‐like growth factor‐1 receptor enhances eribulin‐induced DNA damage in colorectal cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4207, doi. 10.1111/cas.15558
- By:
- Publication type:
- Article
miR‐92a‐3p encapsulated in bone metastatic mammary tumor cell–derived extracellular vesicles modulates mature osteoclast longevity.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4219, doi. 10.1111/cas.15557
- By:
- Publication type:
- Article
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4267, doi. 10.1111/cas.15556
- By:
- Publication type:
- Article
Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4193, doi. 10.1111/cas.15555
- By:
- Publication type:
- Article
Cancerous pH‐responsive polycarboxybetaine‐coated lipid nanoparticle for smart delivery of siRNA against subcutaneous tumor model in mice.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4339, doi. 10.1111/cas.15554
- By:
- Publication type:
- Article
Comprehensive analyses of N<sup>6</sup>‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4289, doi. 10.1111/cas.15553
- By:
- Publication type:
- Article
Paving the road to make chimeric antigen receptor‐T‐cell therapy effective against solid tumors.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4020, doi. 10.1111/cas.15552
- By:
- Publication type:
- Article
SAR1A regulates the RhoA/YAP and autophagy signaling pathways to influence osteosarcoma invasion and metastasis.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4104, doi. 10.1111/cas.15551
- By:
- Publication type:
- Article
Alvocidib inhibits IRF4 expression via super‐enhancer suppression and adult T‐cell leukemia/lymphoma cell growth.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4092, doi. 10.1111/cas.15550
- By:
- Publication type:
- Article
EIF3B stabilizes PTGS2 expression by counteracting MDM2‐mediated ubiquitination to promote the development and progression of malignant melanoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4181, doi. 10.1111/cas.15543
- By:
- Publication type:
- Article
Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4070, doi. 10.1111/cas.15537
- By:
- Publication type:
- Article
Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4258, doi. 10.1111/cas.15458
- By:
- Publication type:
- Article
Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4048, doi. 10.1111/cas.15437
- By:
- Publication type:
- Article
In this Issue.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4017, doi. 10.1111/cas.14966
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4013, doi. 10.1111/cas.14965
- Publication type:
- Article
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4059, doi. 10.1111/cas.15488
- By:
- Publication type:
- Article